Prostatepedia

06/02/2026

In this issue, we hear from a variety of key players in the prostate cancer world – from academic researchers to those in industry – talk about the array of immunotherapeutic approaches to prostate cancer.

We focus in particular on T cell engagers, some of which are in Phase III clinical trials. Not yet FDA-approved, but close. We also touch on the promise of CAR T and its evolving story.

In this issue, we hear from a variety of key players in the prostate cancer world – from academic researchers to those in industry – talk about the array of immunotherapeutic approaches to prostate cancer.

02/20/2024

Our research team has taken our own unique approach to this by focusing our efforts on building a partnership between members of the black community affected by prostate cancer and our research team to try and make sure that everything we do in collaboration with the community.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/19/2024

Building the trust and educating them on the importance of screening is key.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/16/2024

We became national when some of local partners moved to other places.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/15/2024

One piece of information that may be valuable is that the screening and detection guidelines have changed.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/14/2024

One extreme side of the debate is, that there really is no difference if you just put everybody in the same access situation.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/13/2024

We became national when some of our local partners moved to other places.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/12/2024

At the health institution level, big institutions often do not necessarily serve the underrepresented minority populations.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/09/2024

It's a couple of things. It starts in pediatrics. It starts with people who are on their way toward college and are less likely to smoke.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/

02/08/2024

We started this effort like everybody does. We reached out to the same people that are always at the table.

Read Dr. Jenney Lee's full interview at
https://online.flippingbook.com/view/707889051/